InvestSMART

Donaco International Limited (ASX: DNA) - Announcements

DELISTED - Current share price for DNA : $0.045

ASX company news and announcements for Donaco International Limited (DNA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Donaco International Limited (DNA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Donaco International Limited (DNA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Donaco International Limited (DNA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 3 Jul 2020 11:03AM $0.038 $0.045 risen by 18.42%
- Entitlement Issue Prospectus 3 Jul 2020 10:54AM $0.038 $0.045 risen by 18.42%
- Non-Renounceable Entitlement Offer to Raise $14.4m 3 Jul 2020 10:53AM $0.038 $0.045 risen by 18.42%
- Donaco Receives Lender Support 15 Jun 2020 1:06PM $0.050 $0.045 fallen by 10%
- CEO Contract Extension 3 Jun 2020 11:59AM $0.050 $0.045 fallen by 10%
- Reopening of Aristo International Hotel Casino Operations 13 May 2020 4:10PM $0.037 $0.045 risen by 21.62%
- Update on Freezing Order for Thai Vendor Shares 7 May 2020 12:50PM $0.037 $0.045 risen by 21.62%
- Quarterly Activities Report & Appendix 4C 30 Apr 2020 12:48PM $0.037 $0.045 risen by 21.62%
- Extension of Temporary Closure of Aristo Hotel Casino Ops 21 Apr 2020 11:29AM $0.037 $0.045 risen by 21.62%
- Update on Progress of Star Vegas Settlement 17 Apr 2020 1:27PM $0.033 $0.045 risen by 36.36%
- DNA Business Update in Response to COVID-19 7 Apr 2020 2:55PM $0.040 $0.045 risen by 12.50%
- Temporary Closure of Aristo Hotel Casino Operations 1 Apr 2020 1:03PM $0.035 $0.045 risen by 28.57%
- Temporary Closure of DNA Star Vegas Casino Operations 31 Mar 2020 8:31AM $0.035 $0.045 risen by 28.57%
- Progress Update on Settlement with Thai Vendor 27 Mar 2020 9:38AM $0.036 $0.045 risen by 25%
- Coronavirus Impact 25 Mar 2020 8:29AM $0.030 $0.045 risen by 50%
- Conclusion of Negotiations and Settlement with Thai Vendor 3 Mar 2020 9:06AM $0.067 $0.045 fallen by 32.84%
- Further Extension of Freezing Order 2 Mar 2020 9:51AM $0.074 $0.045 fallen by 39.19%
- 1H FY20 Investor Presentation 28 Feb 2020 9:09AM $0.075 $0.045 fallen by 40%
- 1H FY20 Results Summary 28 Feb 2020 9:08AM $0.075 $0.045 fallen by 40%
- Appendix 4D and Half Year Financial Report 28 Feb 2020 9:06AM $0.075 $0.045 fallen by 40%
- 1H FY20 Results - Investor Briefing Conference Call Details 24 Feb 2020 12:47PM $0.077 $0.045 fallen by 41.56%
- Coronavirus Impact 12 Feb 2020 3:05PM $0.080 $0.045 fallen by 43.75%
- Appointment of Executive Directors 11 Feb 2020 9:28AM $0.073 $0.045 fallen by 38.36%
- Change of Company Secretary 7 Feb 2020 12:14PM $0.072 $0.045 fallen by 37.50%
- Update on Litigation Matters 3 Feb 2020 10:55AM $0.073 $0.045 fallen by 38.36%

151 - 175 of 511 results

Page 7 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.